Skip to main content
Clinical Trials/NCT01369446
NCT01369446
Completed
Not Applicable

Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage

Progyny, Inc.5 sites in 1 country160 target enrollmentJune 2011
ConditionsInfertility

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infertility
Sponsor
Progyny, Inc.
Enrollment
160
Locations
5
Primary Endpoint
Eeva System correctly predicts on day 2 those embryos that will reach blastocyst stage at day 5.
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to demonstrate that the Eeva System may be used to identify embryos on Day 2 that are most likely to form blastocysts.

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
April 2012
Last Updated
13 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs.
  • At least 18 years of age.
  • Total antral follicle count of at least 12 as measured by ultrasound prior to stimulation.
  • Basal FSH \< 10 IU.
  • At least 8 normally fertilized eggs (2PN.)
  • Fertilization using only ejaculated sperm (fresh or frozen) - no surgically removed sperm.
  • Willing to comply with study protocol and procedures and able to speak English.

Exclusion Criteria

  • Planned preimplantation genetic diagnosis or preimplantation genetic screening.
  • Gestational carriers.
  • Use of reinseminated eggs.
  • Concurrent participation in another clinical study.
  • Previous enrollment in this clinical study.
  • History of cancer.

Outcomes

Primary Outcomes

Eeva System correctly predicts on day 2 those embryos that will reach blastocyst stage at day 5.

Time Frame: Embryos cultured through blastocyst stage (Day 5).

Imaging data will be manually analyzed to validate parameters previously determined to be predictive of blastocyst formation.

Secondary Outcomes

  • Pregnancy Outcome(Assessed at post embryo transfer day 12-14, post transfer week 5-8, and post transfer week 9-12.)

Study Sites (5)

Loading locations...

Similar Trials